Thyroid Hormone Withdrawal Further Exacerbates Oxidative Stress in Patients with Thyroid Carcinoma

K. Unluhizarci, A. Kiriş, K. Kose, E. Tanrıkulu, Z. Karaca, F. Tanrıverdi, F. Keleştimur
{"title":"Thyroid Hormone Withdrawal Further Exacerbates Oxidative Stress in Patients with Thyroid Carcinoma","authors":"K. Unluhizarci, A. Kiriş, K. Kose, E. Tanrıkulu, Z. Karaca, F. Tanrıverdi, F. Keleştimur","doi":"10.1055/s-0035-1565192","DOIUrl":null,"url":null,"abstract":"Abstract Purpose: Hypothyroidism has profound effects on multiple organs and systems including cellular oxidative damage. Thus, we aimed to investigate the effects of acute hypothyroidism on oxidative stress in patients with differentiated thyroid carcinoma (DTC). Patients: 33 patients with DTC were involved in the study. 23 healthy subjects matched for age and body mass index (BMI) served as control group. Fasting blood sample was obtained for the determination of blood chemistry, lipids, myeloperoxidase (MPO) activity, total lipid hydroperoxide (LHP), pyrrolized protein, protein carbonyl compounds (PCC), advanced oxidation protein products (AOPP) and thiol levels before and after thyroid hormone withdrawal (THW) in patients with DTC. Results: MPO activity, total LHP, pyrrolized protein, PCC and AOPP levels were significantly higher, but thiol levels were significantly lower in patients with DTC while on L-thyroxine treatment than those of healthy subjects. At acute hypothyroid status after THW, MPO activity, total LHP, pyrrolized protein, PCC and AOPP levels further increased, thiol levels further decreased in patients with DTC as compared to healthy subjects and to their on L-thyroxine treatment period. Conclusions: This study showed an increased oxidative stress in patients with DTC which is further exacerbated with acute hypothyroidism upon THW. This situation may have treatment implications such as antioxidant therapy, at least during THW.","PeriodicalId":342775,"journal":{"name":"Experimental and Clinical Endocrinology & Diabetes (Barth)","volume":"21 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and Clinical Endocrinology & Diabetes (Barth)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0035-1565192","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

Abstract

Abstract Purpose: Hypothyroidism has profound effects on multiple organs and systems including cellular oxidative damage. Thus, we aimed to investigate the effects of acute hypothyroidism on oxidative stress in patients with differentiated thyroid carcinoma (DTC). Patients: 33 patients with DTC were involved in the study. 23 healthy subjects matched for age and body mass index (BMI) served as control group. Fasting blood sample was obtained for the determination of blood chemistry, lipids, myeloperoxidase (MPO) activity, total lipid hydroperoxide (LHP), pyrrolized protein, protein carbonyl compounds (PCC), advanced oxidation protein products (AOPP) and thiol levels before and after thyroid hormone withdrawal (THW) in patients with DTC. Results: MPO activity, total LHP, pyrrolized protein, PCC and AOPP levels were significantly higher, but thiol levels were significantly lower in patients with DTC while on L-thyroxine treatment than those of healthy subjects. At acute hypothyroid status after THW, MPO activity, total LHP, pyrrolized protein, PCC and AOPP levels further increased, thiol levels further decreased in patients with DTC as compared to healthy subjects and to their on L-thyroxine treatment period. Conclusions: This study showed an increased oxidative stress in patients with DTC which is further exacerbated with acute hypothyroidism upon THW. This situation may have treatment implications such as antioxidant therapy, at least during THW.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
甲状腺激素停用可进一步加剧甲状腺癌患者的氧化应激
摘要目的:甲状腺功能减退症对包括细胞氧化损伤在内的多器官系统有深远的影响。因此,我们旨在探讨急性甲状腺功能减退症对分化型甲状腺癌(DTC)患者氧化应激的影响。患者:33例DTC患者参与研究。23名年龄、体重指数(BMI)相匹配的健康受试者作为对照组。取空腹血,测定DTC患者甲状腺激素停药(THW)前后血液化学、血脂、髓过氧化物酶(MPO)活性、总脂质氢过氧化物(LHP)、吡罗化蛋白、蛋白羰基化合物(PCC)、高级氧化蛋白产物(AOPP)和硫醇水平。结果:DTC患者在l -甲状腺素治疗期间MPO活性、总LHP、吡啶化蛋白、PCC和AOPP水平显著高于正常对照组,而硫醇水平显著低于正常对照组。在THW后的急性甲状腺功能减退状态下,与健康受试者和l -甲状腺素治疗期相比,DTC患者的MPO活性、总LHP、吡啶化蛋白、PCC和AOPP水平进一步升高,硫醇水平进一步降低。结论:本研究显示DTC患者氧化应激增加,并在THW后进一步加重急性甲状腺功能减退。这种情况可能有治疗意义,如抗氧化治疗,至少在THW期间。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Thyroid Hormone Withdrawal Further Exacerbates Oxidative Stress in Patients with Thyroid Carcinoma Serum Levels of Copeptin are Decreased in Gestational Diabetes Mellitus The Effect of Simvastatin on Plasma Steroid Hormone Levels in Metformin-Treated Women with Non-Classic Congenital Adrenal Hyperplasia
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1